Henderson Jane 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Henderson Jane（CIK 1422304）在 2 家公司共报告 28 笔 SEC Form 4 内部人交易（最近一笔 2026-09-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 158,371 | $0 |
| 2026-07-24 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 15,000 | $0 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 811 | $65,707 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 900 | $74,340 |
| 2026-05-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 289 | $24,033 |
| 2026-04-17 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 2,000 | $180,000 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 900 | $76,014 |
| 2026-04-03 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,100 | $94,006 |
| 2026-03-27 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 2,000 | $170,000 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 406 | $29,094 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 300 | $20,829 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 994 | $70,027 |
| 2026-03-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 300 | $20,481 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 792 | $51,646 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,108 | $73,294 |
| 2026-02-04 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 100 | $6,689 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,920 | $142,330 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 4,080 | $306,816 |
| 2026-01-06 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 2,000 | $160,000 |
| 2025-12-23 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,500 | $120,000 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | 董事 | 卖出 | 9,398 | $0 |
| 2025-12-05 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,500 | $112,500 |
| 2025-11-28 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,500 | $105,000 |
| 2025-11-14 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 2,000 | $130,000 |
| 2025-11-13 | Apogee Therapeutics, Inc. (APGE) | Chief Financial Officer | 卖出 | 1,000 | $60,000 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03